[go: up one dir, main page]

DK0560822T3 - Fremgangsmåde til fremstilling af en fast enhedsdosisform med styret frigørelse - Google Patents

Fremgangsmåde til fremstilling af en fast enhedsdosisform med styret frigørelse

Info

Publication number
DK0560822T3
DK0560822T3 DK91920733.2T DK91920733T DK0560822T3 DK 0560822 T3 DK0560822 T3 DK 0560822T3 DK 91920733 T DK91920733 T DK 91920733T DK 0560822 T3 DK0560822 T3 DK 0560822T3
Authority
DK
Denmark
Prior art keywords
controlled release
preparation
unit dose
fixed unit
release form
Prior art date
Application number
DK91920733.2T
Other languages
Danish (da)
English (en)
Inventor
Per Johan Gunnar Lundberg
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Application granted granted Critical
Publication of DK0560822T3 publication Critical patent/DK0560822T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Control Of Vending Devices And Auxiliary Devices For Vending Devices (AREA)
  • Compositions Of Oxide Ceramics (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
DK91920733.2T 1990-12-07 1991-12-03 Fremgangsmåde til fremstilling af en fast enhedsdosisform med styret frigørelse DK0560822T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9003904A SE9003904D0 (sv) 1990-12-07 1990-12-07 Method for the manufacture of a pharmaceutical dosage form

Publications (1)

Publication Number Publication Date
DK0560822T3 true DK0560822T3 (da) 1996-03-11

Family

ID=20381123

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91920733.2T DK0560822T3 (da) 1990-12-07 1991-12-03 Fremgangsmåde til fremstilling af en fast enhedsdosisform med styret frigørelse

Country Status (20)

Country Link
US (1) US5419918A (fr)
EP (1) EP0560822B1 (fr)
JP (1) JP3239319B2 (fr)
AT (1) ATE130188T1 (fr)
AU (1) AU659114B2 (fr)
CA (1) CA2097175A1 (fr)
DE (1) DE69114721T2 (fr)
DK (1) DK0560822T3 (fr)
ES (1) ES2079689T3 (fr)
FI (1) FI932552L (fr)
GR (1) GR3018685T3 (fr)
HU (1) HUT64212A (fr)
IE (1) IE914229A1 (fr)
IS (1) IS3789A7 (fr)
NO (1) NO932054L (fr)
PL (1) PL168605B1 (fr)
PT (1) PT99721A (fr)
SE (1) SE9003904D0 (fr)
WO (1) WO1992010169A1 (fr)
YU (1) YU182091A (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3598049B2 (ja) * 1992-09-18 2004-12-08 山之内製薬株式会社 ハイドロゲル徐放性製剤
AU682827B2 (en) 1992-09-18 1997-10-23 Astellas Pharma Inc. Sustained-release hydrogel preparation
ES2059260B1 (es) * 1992-10-06 1995-04-16 Espanola Prod Quimicos Procedimiento de preparacion de comprimidos conteniendo diclofenaco; dispersables en agua.
US5393765A (en) * 1993-12-13 1995-02-28 Hoffmann-La Roche Inc. Pharmaceutical compositions with constant erosion volume for zero order controlled release
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
IN186245B (fr) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
JP2000034224A (ja) * 1998-05-11 2000-02-02 Freunt Ind Co Ltd 徐放性錠剤、その添加剤組成物及びそれらの製造方法
US6368625B1 (en) 1998-08-12 2002-04-09 Cima Labs Inc. Orally disintegrable tablet forming a viscous slurry
US6214381B1 (en) 1998-09-08 2001-04-10 Effcon, Inc. Methazolamide composition and method of use
WO2003011256A1 (fr) * 2001-07-30 2003-02-13 Sun Pharmaceutical Industries Limited Composition pharmaceutique d'agent procinetique a liberation orale controlee
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
US20040185093A1 (en) * 2003-03-18 2004-09-23 Szymczak Christopher E. Compositions containing sucralose
US20060062811A1 (en) * 2004-09-21 2006-03-23 Szymczak Christopher E Medicinal cooling emulsions
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
BR112015026418B1 (pt) * 2013-04-16 2022-10-04 Murray And Poole Enterprises Limited Formulação de liberação prolongada de colchicina e uso da referida formulação de liberação prolongada de colchicina
US9980946B1 (en) 2017-01-25 2018-05-29 Effcon Laboratories, Inc. Extended release methazolamide formulation
JP7426685B2 (ja) * 2018-06-14 2024-02-02 株式会社東洋新薬 錠剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
FR2525474A1 (fr) * 1982-04-26 1983-10-28 Roussel Uclaf Nouvelle forme pharmaceutique orale de clometacine
CA1247852A (fr) * 1983-12-20 1989-01-03 Akihiko Nomura Methode pour prevenir l'agglomeration de poudres
US4795327A (en) * 1984-03-26 1989-01-03 Forest Laboratories, Inc. Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
KR910002669B1 (ko) * 1986-12-25 1991-05-03 데이산세이야꾸 가부시끼가이샤 서방성 과립 및 그를 함유하는 지속성 복합과립
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US4971805A (en) * 1987-12-23 1990-11-20 Teysan Pharmaceuticals Co., Ltd. Slow-releasing granules and long acting mixed granules comprising the same
US5024842A (en) * 1988-04-28 1991-06-18 Alza Corporation Annealed coats
CA2002492A1 (fr) * 1988-11-11 1990-05-11 Sandra T. A. Malkowska Compose pharmaceutique contenant une resine echangeuse d'ions

Also Published As

Publication number Publication date
EP0560822A1 (fr) 1993-09-22
HU9301672D0 (en) 1993-09-28
EP0560822B1 (fr) 1995-11-15
IE914229A1 (en) 1992-06-17
YU182091A (sh) 1994-04-05
AU659114B2 (en) 1995-05-11
WO1992010169A1 (fr) 1992-06-25
NO932054D0 (no) 1993-06-04
HUT64212A (en) 1993-12-28
FI932552A0 (fi) 1993-06-04
SE9003904D0 (sv) 1990-12-07
JP3239319B2 (ja) 2001-12-17
CA2097175A1 (fr) 1992-06-08
AU8930991A (en) 1992-07-08
PL299376A1 (en) 1994-03-07
PL168605B1 (pl) 1996-03-29
FI932552A7 (fi) 1993-06-04
IS3789A7 (is) 1992-06-08
NO932054L (no) 1993-06-04
JPH06503310A (ja) 1994-04-14
DE69114721D1 (de) 1995-12-21
DE69114721T2 (de) 1996-04-18
ATE130188T1 (de) 1995-12-15
US5419918A (en) 1995-05-30
GR3018685T3 (en) 1996-04-30
FI932552L (fi) 1993-06-04
PT99721A (pt) 1993-04-30
ES2079689T3 (es) 1996-01-16

Similar Documents

Publication Publication Date Title
DK0560822T3 (da) Fremgangsmåde til fremstilling af en fast enhedsdosisform med styret frigørelse
EE04218B1 (et) Toimeainena klodronaati ja ekstsipiendina ränistatud mikrokristallilist tselluloosi sisaldav farmatseutiline preparaat ning farmatseutilise preparaadi tootmismeetod
DE3480705D1 (de) Gewisse 3-(5-aminopentyl)-amino-1-benzazepin-2-on-1-alkansaeuren, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung.
ATE260645T1 (de) Agitationsunabhängige pharmazeutische multiple- unit-retardzubereitungen und verfahren zu ihrer herstellung
ATE151764T1 (de) Neue benzopyran-derivate, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltenden zubereitungen
DK0869808T3 (da) Anvendelse af Glu-Trp-dipeptider til fremstilling af et lægemiddel til behandling af forskellige tilstande, der involverer neovaskularisation
DK162992C (da) Analogifremgangsmaade til fremstilling af 1-piperazinyl-3-phenyl-indanderivater eller syreadditionssalte deraf
DE3575927D1 (de) Purinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitung.
NO178858C (no) Analogifremgangsmåte for fremstilling av substituerte 4-fenyl-4-piperidinkarboksamider med både lokal anestetisk og analgetisk effekt
NO994275D0 (no) Nikotinsyrepreparater til behandling av hyperlipidemi og tilknyttede fremgangsmÕter
ES8505379A1 (es) Un metodo de fabricar 1, 4-dihidropiridina-3-carboxilatos
SE8901003L (sv) Snabbloesliga preparat
NO170931C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 2-alkylbenzimidazolderivater
DK93485D0 (da) Farmaceutisk praeparat til behandling af hypertension og thromboemboliske sygdomme
DK204484A (da) Fremgangsmaade til fremstilling af et basesalt af piroxicam aflejret paa en farmaceutisk acceptabel baerer
DK257381A (da) Fremgangsmaade til fremstilling af 6-(p-acylaminophenyl)-4,5-dihydro-3(2h)-pyridazioner
FR2673105B1 (fr) Nouvelles compositions pharmaceutiques, notamment pour le traitement des colopathies fonctionnelles, et procedes de preparation de compositions et de medicaments, notamment pour le traitement de ces affections.
DK0796256T3 (da) Fremgangsmåde til fremstilling af ranitidin
HUP9904402A2 (hu) Polihidroxi-fenol-származékok, alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények
DK162286C (da) Penemderivat, farmaceutisk praeparat indeholdende dette, anvendelse af derivatet samt fremgangsmaader til fremstilling deraf
DE69905490D1 (de) Benzofuranderivate, verfahren zu ihrer herstellung, ihre anwendung als medikament und sie enthaltende pharmazeutische zubereitungen
IT1226045B (it) Derivati tetraidrochinolici
SE8401968D0 (sv) A method for preparing well absorptive oral drug dosage forms of medicinal 1,4-dihydropyridine derivatives
DK598184D0 (da) 3-aryl-1,2-benzisoxazolsulfonyl- og -sulfinylalkansyrer og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse som laegemidler